MicroED for the study of protein–ligand interactions and the potential for drug discovery

被引:0
|
作者
Lisa J. Clark
Guanhong Bu
Brent L. Nannenga
Tamir Gonen
机构
[1] University of California,Department of Biological Chemistry
[2] Los Angeles,Chemical Engineering, School for Engineering of Matter, Transport and Energy
[3] Arizona State University,Center for Applied Structural Discovery, Biodesign Institute
[4] Arizona State University,Department of Physiology
[5] University of California,Howard Hughes Medical Institute
[6] Los Angeles,undefined
[7] University of California,undefined
[8] Los Angeles,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Microcrystal electron diffraction (MicroED) is an electron cryo-microscopy (cryo-EM) technique used to determine molecular structures with crystals that are a millionth the size needed for traditional single-crystal X-ray crystallography. An exciting use of MicroED is in drug discovery and development, where it can be applied to the study of proteins and small molecule interactions, and for structure determination of natural products. The structures are then used for rational drug design and optimization. In this Perspective, we discuss the current applications of MicroED for structure determination of protein–ligand complexes and potential future applications in drug discovery.
引用
收藏
页码:853 / 858
页数:5
相关论文
共 50 条
  • [41] Use of computational modelling to study protein- ligand interactions and ligand-ligand interactions
    Thilakarathne, Vindya
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [42] Evolution of biophysical tools for quantitative protein interactions and drug discovery
    Harish, Mahalakshmi
    Venkatraman, Prasanna
    EMERGING TOPICS IN LIFE SCIENCES, 2021, 5 (01) : 1 - 12
  • [43] Essential considerations for using protein-ligand structures in drug discovery
    Warren, Gregory L.
    Do, Thanh D.
    Kelley, Brian P.
    Nicholls, Anthony
    Warren, Slephen D.
    DRUG DISCOVERY TODAY, 2012, 17 (23-24) : 1270 - 1281
  • [44] Harnessing systematic protein-ligand interaction fingerprints for drug discovery
    Zhao, Zheng
    Bourne, Philip E.
    DRUG DISCOVERY TODAY, 2022, 27 (10)
  • [45] An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions
    Peltier, JM
    Askovic, S
    Becklin, RR
    Chepanoske, CL
    Ho, YSJ
    Kery, V
    Lai, SP
    Mujtaba, T
    Pyne, M
    Robbins, PB
    von Rechenberg, M
    Richardson, B
    Savage, J
    Sheffield, P
    Thompson, S
    Weir, L
    Widjaja, K
    Xu, NF
    Zhen, YJ
    Boniface, JJ
    INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2004, 238 (02) : 119 - 130
  • [46] Breaking the spell: drug discovery based on modulating protein-protein interactions
    Strosberg, AD
    EXPERT REVIEW OF PROTEOMICS, 2004, 1 (02) : 141 - 143
  • [47] Targeting Protein-Protein Interactions and Fragment-Based Drug Discovery
    Valkov, Eugene
    Sharpe, Tim
    Marsh, May
    Greive, Sandra
    Hyvoenen, Marko
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 145 - 179
  • [48] Statistical Potential for Modeling and Ranking of Protein-Ligand Interactions
    Fan, Hao
    Schneidman-Duhovny, Dina
    Irwin, John J.
    Dong, Guangqiang
    Shoichet, Brian K.
    Sail, Andrej
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (12) : 3078 - 3092
  • [49] Clustering Protein Binding Pockets and Identifying Potential Drug Interactions: A Novel Ligand-Based Featurization Method
    Stevenson, Garrett A.
    Kirshner, Dan
    Bennion, Brian J.
    Yang, Yue
    Zhang, Xiaohua
    Zemla, Adam
    Torres, Marisa W.
    Epstein, Aidan
    Jones, Derek
    Kim, Hyojin
    Bennett, W. F. Drew
    Wong, Sergio E.
    Allen, Jonathan E.
    Lightstone, Felice C.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (21) : 6655 - 6666
  • [50] Energetics-Based Discovery of Protein-Ligand Interactions on a Proteomic Scale
    Liu, Pei-Fen
    Kihara, Daisuke
    Park, Chiwook
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 408 (01) : 147 - 162